首页 > 市场调查报告书 > 医疗设备

e保健区块链

市场调查报告书

商品编码

1629892

药品供应链管理市场的全球区块链 - 2025-2033

Global Blockchain in Pharmaceutical Supply Chain Management Market - 2025-2033

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球区块链医药供应链管理市场规模达12.7亿美元，预计2033年将达到65.7亿美元，2025-2033年预测期间复合年增长率为21.5%。

区块链是一种去中心化的分散式帐本技术，可以安全地记录众多电脑之间的交易。在药品供应链的背景下，它维护着涉及药品的每笔交易（从生产到分销到最终用户）的不可变且透明的记录。该系统允许所有利害关係人、製造商、分销商、药房和监管机构存取有关药品状态和有效性的即时资料。区块链的加密性质可以保护敏感资料免遭未经授权的存取和操纵。区块链透过智慧合约实现活动自动化，可以简化营运、最大限度地降低管理成本并缩短供应链时间。

资料安全性、透明度和可追溯性的提高是预测期内推动市场的驱动因素。为了解决假药数量增加的严重问题，推出了药品追溯服务。例如，2024 年 11 月，埃塞俄比亚食品药物管理局 (EFDA) 和 Medical Value Chain 宣布建立战略合作伙伴关係，以实施尖端的基于区块链的药品追踪系统。这有助于打击假药并确保安全性和真实性。

市场动态：

驱动程式和限制

提高安全性、透明度和可追溯性

资料安全性、透明度和可追溯性的提高预计将成为全球区块链在药品供应链管理市场成长的重要因素。随着製药业面临假药、资料外洩和监管合规等挑战，区块链作为一种革命性的方法出现，可以有效解决这些关键问题。

提高资料安全性是区块链技术最吸引人的好处之一。区块链使用去中心化且不可变的分类帐来确保所有交易记录都被安全存储，并且在没有有效授权的情况下不能被编辑或销毁。此功能逐渐降低了资料外洩和操纵的可能性，这在旧的集中式系统中很常见。近年来，资料外洩事件屡屡发生。例如，2023 年，超过 540 个组织和 1.12 亿个人涉及向 HHS 民权办公室 (OCR) 报告的医疗保健资料外洩事件，而 2022 年有 590 个组织和 4,860 万受影响个人。资料到 2022 年，将有超过 100 万笔记录被洩露，另外还有 14 起资料外洩事件，超过 50 万笔记录。区块链技术在资料安全方面发挥着至关重要的作用。

全球假药数量不断增加是驱动因素之一，需要药品追溯服务来克服假药的生产。例如，根据辉瑞公司发表的一篇文章，至少有 104 种辉瑞药品已在超过 116 个国家被证实有仿冒版。据药品安全研究所 (PSI) 称，2023 年，执法官员在 142 个国家发现了 6,897 起药品假冒、非法转移和窃盗事件。 2023 年，PSI 记录了 4,894 人因药物犯罪被捕，这是连续 22 年资料中逮捕人数最多的一次。因此，越来越多的资料外洩和假药的生产增加了药品供应链管理市场对区块链的需求。

初期投资高

高初始投资等因素预计将阻碍全球区块链在医药供应链管理市场的发展。实施区块链解决方案需要大量的前期支出，包括对技术基础设施、软体开发和员工培训的投资。组织必须购买适当的技术和软体来实现区块链操作，这可能是一项重大成本。此外，建立和管理这些系统所需的专业技能也推高了价格。许多企业可能很难证明这些费用的合理性，特别是当投资回报 (ROI) 并不立即明显时。这种犹豫可能会阻碍区块链技术在医药供应链中的全面采用。

Blockchain is a decentralized, distributed ledger technology that securely records transactions between numerous computers. In the context of pharmaceutical supply chains, it maintains an immutable and transparent record of every transaction involving pharmaceutical products, from production to distribution to end users. This system allows all stakeholders, manufacturers, distributors, pharmacies, and regulators to access real-time data about the status and validity of pharmaceuticals. The cryptographic nature of blockchain safeguards sensitive data from unauthorized access and manipulation. Blockchain, by automating activities via smart contracts, can streamline operations, minimize administrative costs, and enhance supply chain timelines.

The improved data security, transparency, and traceability is the driving factor that drives the market over the forecast period. To address critical concerns about increasing the number of counterfeit pharmaceuticals, drug traceability services are launched. For instance, in November 2024, the Ethiopia Food and Drug Authority (EFDA), and Medical Value Chain announced strategic partnerships to implement cutting-edge blockchain-enabled pharmaceutical track and track system. This helps in combating counterfeit medicines and ensuring safety, authenticity.

Market Dynamics: Drivers & Restraints

Improved security, transparency, and traceability

Improved data security, transparency, and traceability is expected to be a significant factor in the growth of the global blockchain in the pharmaceutical supply chain management market. As the pharmaceutical industry faces challenges such as counterfeit pharmaceuticals, data breaches, and regulatory compliance, blockchain emerges as a revolutionary approach that effectively addresses these critical concerns.

Improved data security is one of the most appealing benefits of blockchain technology. Blockchain uses a decentralized and immutable ledger to ensure that all transaction records are securely stored and cannot be edited or destroyed without valid authority. This feature gradually decreases the likelihood of data breaches and manipulation, which are common in older centralized systems. In recent times, there have been many data breaches. For instance, in 2023, more than 540 organizations and 112 million individuals were implicated in healthcare data breaches reported to the HHS Office for Civil Rights (OCR), compared to 590 organizations and 48.6 million impacted individuals in 2022. There were 11 reported healthcare data breaches of more than 1 million records in 2022 and a further 14 data breaches of over 500,000 records. Blockchain technology plays a crucial role in data security.

The increasing number of counterfeit pharmaceuticals across the globe is one of the driving factors and it needs drug traceability services to overcome the production of counterfeit pharmaceuticals. For instance, according to an article published by Pfizer, counterfeit versions of at least 104 Pfizer medicines have been confirmed in more than 116 countries. According to the Pharmaceutical Security Institute (PSI), law enforcement officials uncovered 6,897 incidents of counterfeiting, illegal diversion, and theft of pharmaceuticals in 142 countries in 2023. The crimes involved more than 2,440 different medicines across every therapeutic category. The PSI documented 4,894 arrests for pharmaceutical crime in 2023, the largest number of arrests achieved in 22 consecutive years of data. So, the increasing number of data breaches and the production of counterfeit pharmaceuticals increase the demand for the blockchain in the pharmaceutical supply chain management market.

High initial investment

Factors such as high initial investment are expected to hamper the global blockchain in pharmaceutical supply chain management market. Implementing blockchain solutions incurs significant upfront expenditures, including investments in technical infrastructure, software development, and employee training. Organizations must purchase the appropriate technology and software to enable blockchain operations, which can be a major cost. Furthermore, the necessity for specialized skills to build and administer these systems drives up prices. Many businesses may struggle to justify these charges, particularly when the return on investment (ROI) is not immediately obvious. This hesitation may hinder the overall adoption of blockchain technology in the pharmaceutical supply chain.

Segment Analysis

The global blockchain in the pharmaceutical supply chain management market is segmented based on offerings, application, type, end-user, and region.

Drug traceability segment is expected to dominate the global blockchain in pharmaceutical supply chain management market share

The drug traceability segment is the most dominant due to its critical role in enhancing safety, compliance, and operational efficiency within the pharmaceutical industry. As the threat of counterfeit drugs grows, stakeholders recognize the importance of strong traceability systems that can ensure the authenticity and integrity of pharmaceutical products throughout their lifecycle. Drug traceability is the process of tracking pharmaceuticals from their point of manufacture to the final consumer. This procedure is critical for preventing counterfeit pharmaceuticals from entering the supply chain, which poses serious threats to patient safety and public health. Blockchain technology provides a decentralized, immutable database that records all drug-related transactions, creating a transparent and traceable history. This feature not only aids in the detection and elimination of counterfeit products but also assures compliance with regulatory standards requiring strict pharmaceutical tracking.

The number of counterfeit pharmaceuticals is increasing day by day. The increase in the number of counterfeit pharmaceuticals increases the demand for drug traceability services. For instance, according to the World Health Organization, at least 1 in 10 medicines in low- and middle-income countries are substandard or falsified. Countries spend an estimated US$ 30.5 billion per year on substandard and falsified medical products. Substandard and falsified medical products are often sold online or in informal markets. Moreover, according to the National Institute of Health, it has been estimated that up to 15% of all sold drugs are fake, and in parts of Africa and Asia this figure exceeds 50%. The FDA estimates that fake drugs comprise approximately 10% of the global medicine market. The number of investigations of possible counterfeit drugs by the FDA has jumped from about five per year in the 1990s to more than 20 per year since 2000.

There are recent launches of blockchain-based drug traceability services. For instance, in May 2024, Merck, a leading scientific and technological firm, introduced the M-Trace Software & Mobile App, a comprehensive data tracking solution for digitizing sterility testing. The software improves overall process safety by automatically documenting data at each stage of the testing process. This decreases the chances of divergence, false positive results, and human error. The increasing number of counterfeit pharmaceuticals and recent launches of blockchain-based drug traceability services drive the market of this segment making the drug traceability segment a dominant one.

Geographical Analysis

North America is expected to hold a significant position in the global blockchain in pharmaceutical supply chain management market share

The blockchain in the pharmaceutical supply chain management market in the North American Region is driven by several key factors that underscore its robust industrial landscape and consumer demand, increasing number of cybercrimes, strong regulatory support, and increasing awareness of the benefits of blockchain technology and increased number of launches.

In recent times, there have been launches of blockchain services in this region. For instance, in May 2023, Patientory Inc., the creator of a blockchain-based, HIPAA-compliant, private medical data ecosystem, announced today that it has launched two solutions, Patientory Consumer Decentralized Application-designed to help patients more efficiently and securely store and earn money from their medical data and Neith Enterprise Dashboard in partnership with Prosper Healthtech, a community-backed organization committed to equity in Birmingham offering a supportive network of organizations throughout the city, including UAB Hospital, PackHealth, and Blue Cross Blue Shield.

The increasing number of cybercrimes is one of the major drivers in this region. The cybercrimes can be reduced by storing the systems securely using software blockchain services. For instance, according to an article posted by Palo Alto Networks in January 2024, Malicious attacks on healthcare have grown exponentially in recent years. According to the HHS Office for Civil Rights (OCR), large breaches increased by 93% between 2018 and 2023. Additionally, large breaches involving ransomware increased by 278%.

The increase in the number of counterfeit pharmaceuticals in this region increases the demand for global blockchain in pharmaceutical supply chain management which helps in the marketing of original products. For instance, in January 2024, the FDA alerted healthcare professionals and consumers that unsafe counterfeit versions of Botox (botulinum toxin) have been found in multiple states and administered to consumers for cosmetic purposes. Moreover, in December 2023, the FDA investigated and announced that a counterfeit Ozempic (semaglutide) injection of 1 milligram (mg) was found and the U.S. drug supply chain seized thousands of units of the product. All these factors make North America hold the highest market share.

Asia Pacific is growing at the fastest pace in the global blockchain in pharmaceutical supply chain management market

Asia Pacific's rapid growth in the Global Blockchain in Pharmaceutical Supply Chain Management Market is driven by a combination of factors including the booming e-commerce sector, increasing industrialization, proactive technology adoption, increasing number of counterfeit versions, and supportive government initiatives. The Asia Pacific area is rapidly industrializing, resulting in rising consumer markets that require improved supply chain visibility and efficiency. Countries like as China, India, and Japan are at the forefront of using blockchain technology to simplify processes and combat counterfeit products.

The rapid expansion of the e-commerce sector is a major driver of blockchain implementation in the Asia Pacific pharmaceutical supply chain. As e-commerce grows more popular, there is a greater demand for efficient and transparent supply chain solutions that guarantee timely delivery and product authenticity. Blockchain technology provides a reliable foundation for tracking pharmaceuticals along the supply chain, giving stakeholders real-time visibility into product movements.

Competitive Landscape

The major global players in the global blockchain in pharmaceutical supply chain management market include IBM, Microsoft, SAP SE, Oracle, Cloud Software Group, Inc., Auxesis Infotech Pvt. Ltd., Omnichain Solutions, Walmart Inc., FarmaTrust, Amazon Web Services, Inc. among others.

Emerging Players

VeChain, Modum, and Everledger among others

Key Developments

In September 2023, the Republic of Mauritius launched a blockchain-based eVerify service. E-Verify is a system that uses blockchain to verify and authenticate information or transactions electronically. Emerging technologies such as blockchain, big data, Artificial Intelligence, and the internet create new ways for consumers to interact while disrupting traditional business models.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global blockchain in pharmaceutical supply chain management market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Offerings
3.2. Snippet by Application
3.3. Snippet by Type
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.2. Improved Data Security, Transparency, And Traceability
- 4.1.3. Restraints
- 4.1.4. High Initial Investment
- 4.1.5. Opportunity
- 4.1.6. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Offerings

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offerings
- 6.1.2. Market Attractiveness Index, By Offerings
6.2. Platform*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Service

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Drug Traceability*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Inventory Monitoring
7.4. Smart Contracts
7.5. Compliance Management
7.6. Payment & Settlement
7.7. Others

8. By Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.1.2. Market Attractiveness Index, By Type
8.2. Private Blockchain*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Public Blockchain
8.4. Hybrid Blockchain

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Manufacturers*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Distributors
9.4. Healthcare Providers

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Offerings
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. The U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Offerings
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. UK
  - 10.3.7.3. France
  - 10.3.7.4. Italy
  - 10.3.7.5. Spain
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Offerings
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Offerings
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
  - 10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), Offerings
  - 10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  - 10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  - 10.6.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. IBM*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Microsoft
12.3. SAP SE
12.4. Oracle
12.5. Cloud Software Group, Inc.
12.6. Auxesis Infotech Pvt. Ltd.
12.7. Omnichain Solutions
12.8. Walmart Inc.
12.9. FarmaTrust
12.10. Amazon Web Services, Inc.

LIST NOT EXHAUSTIVE